Pharma News

“Back in the U.S.A.”: FDA Launches PreCheck Program to Boost Domestic Drug Manufacturing

FDA approves Jazz Pharmaceuticals’ Modeyso as first drug for ultra-rare brain cancer

Santen and RemeGen sign licence deal for retinal disease injection

Lupin launches Bosentan tablets for oral suspension in US market

AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease

The European Commission (EC) has granted marketing authorisation to SpringWorks Therapeutics, a subsidiary of Merck KGaA

HCM CITY — AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its commitment to building a sustainable, people-centred workp...

Sanofi’s Tzield (teplizumab) has become the first immunotherapy to be approved for type 1 diabetes in the UK after being authorised by the Medicines and Healthcare products Regulatory Agency...

FDA Grants Breakthrough Therapy To Daraxonrasib For KRAS G12+ Metastatic Pancreatic Cancer

Novo Nordisk’s Wegovy (Semaglutide) gets accelerated US approval for serious liver condition

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to the drug HLD-0915 for the treatment of patients with metastatic castration-resistant prostate cancer (mCRP...

AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois.